Bivatuzumab Uses, Dosage, Side Effects and more
Bivatuzumab (previously BIWA 4) is a humanized monoclonal antibody against CD44 v6.
| Trade Name | Bivatuzumab |
| Generic | Bivatuzumab |
| Bivatuzumab Other Names | Bivatuzumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in cancer/tumors (unspecified) and head and neck cancer.
